Discover the whole team behind our project, our collaborators and other partners
Vaxxel Team
Denis Cavert
MSc. Biochemical Engineering INSA / MS ESSEC Former head of Baxter Vaccines Europe Business Unit Director at Baxter and Merck Serono, with sales up to 250m€
CEO
Dr. Manuel Rosa-Calatrava
Ph.D., Research Director at INSERM, Deputy head of Virpath University lab, head of Virnext 125 publications / 25 patents Founder of Signia Therapeutics and VirexpR
Scientific Advisor
Pr. Guy Boivin
Professor and principal researcher in virology at the University of Laval (Québec) 400 publications / 10 patents First to describe pathogenesis of hMPV
Clinical Development
Dr. Caroline Chupin
PharmD and Bioprocess Engineer Cell culture and process development PhD Student
Process Development
Marjorie Ray
MSc Cellular and Molecular Biology Expertise in optimisation of virus production 15 years experience un Biotech and CDMP
Biomanufacturing
First-in-class international Founding Team
Dr. Bernard Fritzel
Clinical Development
Physician Former VP International Scientific & Clinical Affairs, Pfizer Vaccines Former VP International Scientific & Medical Affairs, Chiron Vaccines Former Director Clinical Research, Sanofi Pasteur Member of the French Covid-19 Vaccine C’tee
Dr. Bernard Fanget
CMC
Engineer and Ph.D, VP Drug Development, NeoVacs Former VP Product Dev. & Production, Abivax Former VP Pharmaceutical Dev. Flamel Former VP Product Dev. & Industrialisation, Sanofi Pasteur Member of the French Covid-19 Vaccine C’tee
Pr. Pieter Neels
Regularory
Physician, Professor of Vaccinology at the University of Namur (Bel.) Former member of CHMP Former Vice President of the EMA Vaccine Working Party
Other partners
Manage cookie consent
To provide the best experiences, we use technologies such as cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent or withdrawing consent may negatively impact certain features and functions.
Functional
Toujours activé
Storage or technical access is strictly necessary for the purpose of legitimate interest of allowing the use of a specific service explicitly requested by the subscriber or Internet user, or for the sole purpose of carrying out the transmission of communication on an electronic communications network.
Préférences
L’accès ou le stockage technique est nécessaire dans la finalité d’intérêt légitime de stocker des préférences qui ne sont pas demandées par l’abonné ou l’internaute.
Statistics
Le stockage ou l’accès technique qui est utilisé exclusivement à des fins statistiques.Storage or technical access that is used exclusively for anonymous statistical purposes. Absent a subpoena, voluntary compliance by your Internet Service Provider, or additional records from a third party, information stored or retrieved for this sole purpose cannot generally not be used to identify you.
Marketing
Storage or technical access is necessary to create Internet user profiles in order to send advertisements, or to track the Internet user on a website or on several websites with similar marketing purposes.